NHSA Reports 2023 Milestones in Basic Medical Insurance Participation and Financials
The National Healthcare Security Administration (NHSA) has published its annual “Healthcare Security Development Statistical Bulletin”...
Policy / Regulatory
BIO’s Chief Lobbyist Nick Shipley Resigns Amid Controversy Over WuXi AppTec
Nick Shipley, the chief lobbyist for the U.S.-based Biotechnology Innovation Organization (BIO), has resigned from...
Shanghai Health Commission Implements Strict Guidelines to Curb Medical Sector Misconduct
The Shanghai Municipal Health Commission has issued the “Implementation Rules for the Nine Guidelines for...
China’s CDE Issues Guidelines for Semaglutide Biosimilar Clinical Trials with Weight Management Focus
The Center for Drug Evaluation (CDE) in China has released a new set of Guidelines...
Beijing Unveils Comprehensive Measures to Boost Innovative Medicine Development
The Beijing Municipal Medical Insurance Bureau, in conjunction with eight other bureaus, has announced a...
Guangzhou and Zhuhai Unveil Measures to Stimulate Biopharmaceutical Industry Growth
In a bid to bolster the biopharmaceutical and health industries, the cities of Guangzhou and...
US Lawmakers Expand Scrutiny on Chinese Biotech Firms with Potential Military Ties
Despite his announced retirement from Congress effective April 19 this year, Mike Gallagher continues to...
China’s National Joint Procurement Office Unveils Renewed Insulin Procurement Contracts
The National Joint Procurement Office in China announced the upcoming renewal of drug procurement contracts...
Shanghai Unveils Massive Investment Projects and Funds to Boost High-Tech Industries
Shanghai has unleashed a flurry of policy-backed project signings and initiatives, marking a significant boost...
Abiomed Recalls Over 66,000 Impella Heart Pumps Due to Serious Injury Risk, FDA Classifies as Class I Event
Johnson & Johnson (J&J, NYSE: JNJ), already embroiled in lawsuits over alleged cancer risks associated...
WuXi AppTec Denies US Allegations of Unauthorized Intellectual Property Transfer
WuXi AppTec (SHA: 603259, HKG: 2359), a leading Contract Research, Development, and Manufacturing Organization (CRDMO)...
China’s National Joint Procurement Office Announces Renewal of Insulin Procurement Contracts Valued at $1.59 Billion
The National Joint Procurement Office in China has announced the renewal of drug procurement contracts...
FDA Reviews Eisai’s Leqembi for Expanded Use as Monthly Alzheimer’s Therapy
The US Food and Drug Administration (FDA) has given the green light to review an...
WuXi AppTec Denies Unauthorized IP Transfer Allegations Amidst Strong Financial Performance
WuXi AppTec (SHA: 603259, HKG: 2359), a China-based Contract Research, Development, and Manufacturing Organization (CRDMO)...
China Unveils Management Measures to Strengthen National Health Emergency Teams
The National Health Commission (NHC), National Administration of Traditional Chinese Medicine, and National Disease Control...
China’s NHC Mandates Enhanced Management and Accessibility of Midwifery Services
The National Health Commission (NHC) has issued a notification with the aim of enhancing the...
NMPA Mandates Electronic Permits for Anesthetic Drugs and Psychotropic Substances
The National Medical Products Administration (NMPA) has issued a new notification aimed at enhancing the...
National Drug Sampling Inspection Report Reveals High Compliance Rates in 2023
The National Institute for Food and Drug Control (NIFDC) has released its “National Drug Sampling...
China’s National Adverse Drug Reaction Report for 2023 Highlights Stability in Reporting Trends
The National Center for ADR Monitoring has released its “National Adverse Drug Reaction Monitoring Annual...
Kobayashi Pharmaceutical Recalls Red Yeast Rice Pills in China Amid Health Concerns
Japan-based Kobayashi Pharmaceutical has reportedly initiated a product recall in the Chinese market for its...